Analysts at Mizuho Remain Bullish on IQVIA (IQV) Following Q4 Results

By Faheem Tahir | March 01, 2026, 4:24 AM

IQVIA Holdings Inc. (NYSE:IQV) is one of the most undervalued AI stocks to buy now.

With significant analyst and hedge fund sentiment, alongside a low forward price-to-earnings (PE) ratio, IQVIA Holdings Inc. (NYSE:IQV) secures a spot on our list of the most undervalued AI stocks to buy now.

Following the company’s fourth-quarter earnings release, analysts at Mizuho and Truist revise their valuation models on IQVIA Holdings Inc. (NYSE:IQV).

Incorporating the company’s Q4 performance, Mizuho lowered its price target on the stock from $266 to $215 on February 23, 2026.  The firm reiterated its ‘Outperform’ rating on IQVIA Holdings Inc. (NYSE:IQV).

Guardant Health, Inc. (GH) Strengthens Health Technology Portfolio with MetaSight Diagnostics Acquisition

Meanwhile, concerns surrounding the potential impact of AI continue to weigh on analyst sentiment at Truist. Alongside the quarterly performance, the company’s re-segmentation prompted the investment bank’s analysts to cut their forward EBITDA multiple from 14x to 13x to incorporate AI headwinds. While maintaining its ‘Buy’ rating, the firm reduced its price target on the stock from $290 to $245 on February 19.

For the fourth quarter, IQVIA Holdings Inc. (NYSE:IQV) reported a top-line growth of 10.30%, taking its revenue to $4.36 billion. As of quarter-end, the company’s R&D backlog climbed to $32.70 billion, while the book-to-bill ratio reached 1.18x.

On an adjusted basis, EPS for the quarter came out at $3.42, a 9.60% increase. Looking ahead, IQVIA Holdings Inc. (NYSE:IQV) expects revenue of $17.15-$17.35 billion and adjusted EPS of $12.55-$12.85. The company announced its quarterly results on February 5, 2026.

IQVIA Holdings Inc. (NYSE:IQV) engages in the provision of clinical research services, commercial analytics, and healthcare intelligence solutions. Leveraging data, technology, and AI, the company helps life sciences companies with drug development, commercialization, and real-world evidence generation worldwide.

While we acknowledge the potential of IQV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 12 Best Beaten Down Technology Stocks to Buy According to Wall Street Analysts and 7 Most Volatile Stocks Under $5 for Day Trading.

Disclosure: None.  Follow Insider Monkey on Google News.

Mentioned In This Article

Latest News